Update and Biodistribution of [F-18]FMDHT pET/CT in Normal Healthy Volunteers and Patients With Metastatic Prostate Cancer - A First in Human Subject Study With [F-18] FMDHT

NCT01724619 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped Study tracer can no longer be obtained at our institution

Conditions

Prostate Cancer

Interventions

DRUG: [F-18] fluorinated dihydrotestosterone (FDHT)

Sponsor

Wake Forest University Health Sciences